Helsinki - Delayed Quote EUR

Remedy Entertainment Oyj (REMEDY.HE)

Compare
13.30 -0.10 (-0.75%)
At close: December 20 at 6:29:52 PM GMT+2
Loading Chart for REMEDY.HE
DELL
  • Previous Close 13.40
  • Open 13.38
  • Bid 13.18 x --
  • Ask 13.20 x --
  • Day's Range 13.10 - 13.38
  • 52 Week Range 12.72 - 26.50
  • Volume 24,265
  • Avg. Volume 9,152
  • Market Cap (intraday) 180.537M
  • Beta (5Y Monthly) 0.61
  • PE Ratio (TTM) --
  • EPS (TTM) -1.37
  • Earnings Date Mar 18, 2025 - Mar 24, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Apr 14, 2023
  • 1y Target Est 20.00

Remedy Entertainment Oyj, a video game company, engages in the development and sale of games for PC and console platforms in Finland. It primarily creates story-driven and visually stunning action games. The company also provides franchises under the Alan Wake, Control, and Max Payne brand names. Remedy Entertainment Oyj was incorporated in 1995 and is headquartered in Espoo, Finland.

www.remedygames.com

361

Full Time Employees

December 31

Fiscal Year Ends

Recent News: REMEDY.HE

View More

Performance Overview: REMEDY.HE

Trailing total returns as of 12/20/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

REMEDY.HE
47.64%
OMX Helsinki_PI
0.00%

1-Year Return

REMEDY.HE
44.81%
OMX Helsinki_PI
0.00%

3-Year Return

REMEDY.HE
61.70%
OMX Helsinki_PI
0.00%

5-Year Return

REMEDY.HE
22.64%
OMX Helsinki_PI
0.00%

Compare To: REMEDY.HE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: REMEDY.HE

View More

Valuation Measures

Annual
As of 12/20/2024
  • Market Cap

    180.54M

  • Enterprise Value

    161.51M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.67

  • Price/Book (mrq)

    2.76

  • Enterprise Value/Revenue

    4.11

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -47.28%

  • Return on Assets (ttm)

    -11.17%

  • Return on Equity (ttm)

    -25.47%

  • Revenue (ttm)

    39.26M

  • Net Income Avi to Common (ttm)

    -18.56M

  • Diluted EPS (ttm)

    -1.37

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    23.12M

  • Total Debt/Equity (mrq)

    6.27%

  • Levered Free Cash Flow (ttm)

    -588k

Research Analysis: REMEDY.HE

View More

Company Insights: REMEDY.HE

Research Reports: REMEDY.HE

View More

People Also Watch